United States · FDA National Drug Code directory
Pirfenidone
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 59651-244_3115f15f-171c-4266-8dc8-5655f56e6acc
- Product NDC
- 59651-244
- Form
- CAPSULE
- Composition / generic term
- Pirfenidone
- Labeler
- Aurobindo Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260420
- Source listing expiry
- 20271231
Source-listed ingredients
- PIRFENIDONE — 267 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (59651-244-27) / 270 CAPSULE in 1 BOTTLE · 59651-244-27
- 4 BLISTER PACK in 1 CARTON (59651-244-28) / 63 CAPSULE in 1 BLISTER PACK (59651-244-63) · 59651-244-28
- 1 BLISTER PACK in 1 CARTON (59651-244-42) / 63 CAPSULE in 1 BLISTER PACK · 59651-244-42
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →